TuHURA Biosciences, Inc./NV SEC filings HURA

TuHURA Biosciences, Inc./NV has 928 filings in SEC EDGAR's recent list, going back to Aug 17, 2010. Its latest annual report, Form ARS, was filed on Jul 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (new debt). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
10-Q Quarterly report Feb 14, 2023 Dec 31, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Feb 11, 2022 Dec 31, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
10-Q Quarterly report Feb 12, 2021 Dec 31, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report May 13, 2020 Mar 31, 2020
10-Q Quarterly report Feb 13, 2020 Dec 31, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report May 14, 2019 Mar 31, 2019
10-Q Quarterly report Feb 11, 2019 Dec 31, 2018
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Feb 14, 2018 Dec 31, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report May 12, 2017 Mar 31, 2017
10-Q Quarterly report Feb 10, 2017 Dec 31, 2016
10-Q Quarterly report Nov 10, 2016 Sep 30, 2016
10-Q Quarterly report May 12, 2016 Mar 31, 2016
10-Q Quarterly report Feb 12, 2016 Dec 31, 2015
10-Q Quarterly report Nov 16, 2015 Sep 30, 2015
10-Q Quarterly report May 15, 2015 Mar 31, 2015
10-Q Quarterly report Feb 12, 2015 Dec 31, 2014
10-Q Quarterly report Nov 7, 2014 Sep 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Nov 8, 2013 Sep 30, 2013
10-Q Quarterly report Aug 12, 2013 Jun 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q Quarterly report Jan 18, 2013 Dec 31, 2012
10-Q/A Amended quarterly report Dec 20, 2012 Sep 30, 2012
10-Q Quarterly report Dec 14, 2012 Sep 30, 2012
10-Q/A Amended quarterly report Jun 5, 2012 Mar 31, 2012
10-Q Quarterly report May 21, 2012 Mar 31, 2012
10-Q Quarterly report Feb 7, 2012 Dec 31, 2011
10-Q Quarterly report Nov 10, 2011 Sep 30, 2011
10-Q Quarterly report May 12, 2011 Mar 31, 2011
10-Q Quarterly report Feb 14, 2011 Dec 31, 2010

Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HURA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Tampa, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1498382
Former names
Kintara Therapeutics, Inc. (until Oct 22, 2024); DelMar Pharmaceuticals, Inc. (until Aug 18, 2020); Berry Only Inc. (until Jan 18, 2013)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.